What is the highest-ROI AI use case for a small ophthalmology practice?

The biggest, safest win is AI ambient scribing paired with AI-assisted diabetic retinopathy screening (IDx-DR, EyeArt, AEYE-DS, RetinaLyze) and AI-supported cataract + refractive surgical planning (ORA System, VERION, Zeiss CALLISTO eye + IOLMaster 700, Pentacam AXL Wave, Alcon ARGOS). A 2026 ophthalmology practice running Modernizing Medicine EMA Ophthalmology AI, Nextech IntelleChart, NextGen Office Ophthalmology, or EyeMD EMR with an ambient scribe (DeepScribe, Abridge, Suki, Heidi, Nuance DAX Copilot) and an AI retina screening layer typically saves 60-90 min of charting per MD per day, lifts diabetic retinopathy screening compliance 30-50% for covered primary-care-referred populations, and reduces IOL calculation rework on premium cases 20-35%. Every finding, surgical plan, IOL selection, and code still requires the treating ophthalmologist to review and sign.

How does the FDA 510(k) framework govern AI use in ophthalmology?

Several ophthalmic AI tools are FDA-cleared or authorized: IDx-DR (autonomous AI diabetic-retinopathy detection, De Novo 2018 + subsequent 510(k)s), EyeArt (510(k) for more-than-mild DR + referable DR), AEYE-DS (De Novo + 510(k) expansions), Notal Vision Home OCT (510(k)), plus a growing catalog of imaging-analytic tools on the FDA AI/ML-enabled medical device list. Tool category matters: CADe (detect) vs CADx (diagnose) vs decision-support-only vs autonomous AI. Autonomous-AI tools (IDx-DR, EyeArt at certain thresholds) carry specific labeling requirements — the ophthalmologist still owns the care-plan decision when a patient screens positive. Decision-support tools are not diagnostic — the physician owns the diagnosis. Review the current 510(k) summary + Indications for Use before deploying any clinical AI tool, and keep the AI pointed at the cleared indication, not an off-label use.

What HIPAA, state medical board, and CMS rules apply to AI in an ophthalmology practice?

Any AI tool that touches patient data must have a BAA on file (HIPAA 45 CFR 164.504(e)). Consumer ChatGPT / Claude.ai / Gemini endpoints are not BAA-covered — route PHI only through HIPAA-compliant enterprise endpoints (DeepScribe BAA, Abridge BAA, Suki BAA, Heidi BAA, DAX Copilot BAA, Modernizing Medicine / Nextech / NextGen / EyeMD built-in AI). State medical boards (CA MBC, TX TMB, FL DOH, NY OPMC, IL DFPR and others) govern scope of practice and in a growing number of states now expect a written AI-usage policy. CMS MIPS / QPP incentivizes diabetic-retinopathy screening (quality measure 117), AAO IRIS Registry participation, and quality reporting; AKS / Stark govern referral + in-office dispensing (optical, premium IOLs, dry-eye devices). Premium IOL (refractive-surgical) and non-covered dry-eye / aesthetic services follow ABN / GA / GY / GZ modifiers and patient-choice rules. Record-retention for ophthalmology charts typically follows state medical-record rules (often 7-10 years, longer for minors).

What AI stack actually works in a 1-5 MD ophthalmology practice in 2026?

Core EHR + PM: Modernizing Medicine EMA Ophthalmology AI, Nextech IntelleChart / NextGen Office Ophthalmology, EyeMD EMR, Compulink Ophthalmology Advantage, Medflow, RevolutionEHR. Ambient scribe: DeepScribe, Abridge, Suki, Heidi, Nuance DAX Copilot, Freed, Sunoh.ai. AI retina screening: IDx-DR (Digital Diagnostics), EyeArt (Eyenuk), AEYE-DS (AEYE Health), RetinaLyze, Optos Silverstone Optomap AI. OCT AI: Heidelberg Spectralis AI, Zeiss Cirrus 6000 + PLEX Elite 9000 AI, Topcon Maestro2 / Triton AI, Notal Vision Home OCT. Cataract + refractive planning: Alcon ORA System, VERION, ARGOS; Zeiss CALLISTO eye + IOLMaster 700; Oculus Pentacam AXL Wave; Haag-Streit Lenstar Myopia + EyeSuite IOL; Alcon PhacoPower + Active Sentry. MIGS planning: Ahmed + preoperative imaging analysis. Dry-eye workup + device: LipiView II / LipiFlow, iLux, TearLab, MiBo, BlephEx, OptiLight / LUMECA IRPL. Patient engagement: Weave, Doctible, Solutionreach, RevenueWell, NexHealth, Klara, Phreesia AI. RCM + prior auth: Office Ally, Availity, Waystar, CoverMyMeds, Glidian, Myndshft. Reputation: BirdEye, Podium, Swell. Marketing: Scorpion Healthcare, Cardinal, Messenger Healthcare Marketing.

What are the fastest AI wins for an ophthalmology owner this quarter?

Three, in order of speed-to-cash. (1) AI ambient scribing on every encounter — MD sees more patients per day, chart closes the same day. (2) FDA-cleared AI diabetic retinopathy screening on diabetic + PCP-referred patients — MIPS quality-measure credit, IRIS registry benchmarks, primary-care referral pipeline, and billing capture on CPT 92250 / CPT Cat III 9225X where applicable. (3) AI-supported cataract + premium-IOL workflow — consent, biometry integration, IOL calculation cross-check, and refractive-expectation-setting reduces rework and lifts premium-IOL conversion. Combined, these typically lift revenue per MD per day 15-25% and reduce denied claims meaningfully within 60-90 days.

How to Use AI for an Ophthalmology Practice in 2026: Retina AI, Cataract Surgical Planning, MIGS, Dry Eye, Optical & Owner Scorecard

Published May 9, 2026 · 16 min read · Happycapy Guide

TL;DR — for the MD-owner

The three highest-ROI AI wins in a 2026 ophthalmology practice are ambient scribing, FDA-cleared AI diabetic retinopathy screening, and AI-supported cataract + premium-IOL surgical planning. Together they save hours of charting, lift DR-screening compliance, and reduce surgical-plan rework.
AI drafts the note, the screening triage, the surgical plan, and the counseling script. The ophthalmologist reviews, corrects, and signs. State boards license the MD, not the software.
FDA 510(k) / De Novo status matters. Autonomous-AI retina tools (IDx-DR, EyeArt at certain thresholds) have specific labeling; decision-support AI is not diagnostic. The physician owns the diagnosis.
PHI travels only through BAA-covered endpoints. Consumer ChatGPT / Claude.ai / Gemini are off-limits for any patient-identifiable data.
Owner rule: every AI-drafted SOAP, surgical plan, IOL recommendation, consent document, recall message, review reply, and ad is reviewed and signed by the ophthalmologist (or delegated supervising clinician) before it leaves the practice.

Why ophthalmology is a high-leverage AI vertical

Ophthalmology is imaging-heavy, volume-high, surgical, and optical-dispense- adjacent. The MD-owner's four chronic problems — charting time, diabetic-retinopathy screening compliance, cataract + premium-IOL plan rework, and non-covered-service (dry eye, aesthetic, optical) capture — all get better with narrow AI assistants running inside a modern ophthalmology EHR + imaging stack. AI does not replace the ophthalmologist's diagnosis, surgical skill, or state-board-licensed judgment; it removes the documentation and coordination tax that eats the clinical day.

This playbook is for the owner of a 1-to-5 MD ophthalmology practice (general, cornea + refractive, retina, glaucoma, or multi-sub-specialty) who wants to use AI across intake, ambient SOAP, retina screening, cataract + MIGS surgical planning, dry eye, optical dispensing, recall, marketing, and owner scorecard — without tripping HIPAA, FDA 510(k) labeling, state medical boards, CMS MIPS rules, AKS / Stark, FTC Endorsement Guides, or TCPA.

The compliance floor (read this first)

HIPAA Privacy + Security + Breach Notification (45 CFR 160 / 164): BAA with every vendor touching PHI; minimum-necessary; encryption in transit + at rest; breach notification.
State medical licensing + board AI guidance: CA MBC, TX TMB, FL DOH, NY OPMC, IL DFPR — scope of practice, supervision, and in a growing number of states a written AI-usage policy.
FDA 510(k) / De Novo / PCCP framework: IDx-DR, EyeArt, AEYE-DS, RetinaLyze, Notal Home OCT, Heidelberg / Zeiss / Topcon OCT AI — know the cleared indication + labeling; don't drift off-label.
CMS MIPS / QPP + AAO IRIS Registry: quality measure 117 (DR screening), patient-safety, promoting-interoperability, cost measures; registry participation.
CPT + ICD-10: 92002 / 92004 / 92012 / 92014 E/M, 92133 / 92134 SCODI, 92250 / 9225X DR imaging, 66984 / 66982 cataract, 65855 LTP, 66170 / 66172 / 66174 / 66183 MIGS, 92310 / 92340 optical dispensing — AI suggests, coder verifies, MD signs.
Premium IOL + non-covered service documentation: ABN + GA / GY / GZ modifiers, patient-choice, billing split between Medicare-covered portion and non-covered premium-refractive portion.
Anti-Kickback + Stark: no patient inducements; strict rules on in-office optical dispensing and manufacturer relationships.
FTC Endorsement Guides 2023 + 2024-2025: no incentivized reviews; before/after photos must be typical results + material connections disclosed.
FTC Act §5 UDAP: no "perfect vision," "glasses-free for life," or unsubstantiated refractive-surgery claims.
State truth-in-advertising: CA B&P §17500, FL §817.06, NY GBL §349, TX DTPA §17.46.
TCPA + state mini-TCPA: written express consent for marketing SMS, quiet hours, opt-out language.
Two-party-consent recording: CA, FL, MA, WA, PA, IL, MT, NH, CT, MD — announce on every call.
HIPAA-safe review replies: no PHI in public responses, even when the patient disclosed some of it.
State AI content disclosure: a handful of states require disclosure when AI writes marketing or patient-facing letters — check state AG guidance.

The ophthalmology AI stack in 2026

EHR + PM: Modernizing Medicine EMA Ophthalmology AI, Nextech IntelleChart, NextGen Office Ophthalmology, EyeMD EMR, Compulink Ophthalmology Advantage, Medflow, RevolutionEHR.
Ambient scribe: DeepScribe, Abridge, Suki, Heidi, Nuance DAX Copilot, Freed, Sunoh.ai.
AI diabetic retinopathy screening (FDA-cleared): IDx-DR (Digital Diagnostics), EyeArt (Eyenuk), AEYE-DS (AEYE Health), RetinaLyze, Optos Silverstone Optomap AI.
OCT + imaging AI: Heidelberg Spectralis AI, Zeiss Cirrus 6000 + PLEX Elite 9000, Topcon Maestro2 / Triton, Optovue Solix, Notal Vision Home OCT.
Cataract + refractive biometry + planning: Alcon ORA System, VERION, ARGOS; Zeiss CALLISTO eye + IOLMaster 700; Oculus Pentacam AXL Wave; Haag-Streit Lenstar Myopia + EyeSuite IOL; Alcon PhacoPower + Active Sentry.
MIGS + glaucoma planning: AI-assisted OCT + visual-field progression analysis.
Dry-eye workup + therapy: LipiView II + LipiFlow (Johnson & Johnson Vision), iLux (Alcon), TearLab, MiBo Thermoflo, BlephEx, OptiLight (Lumenis), Systane iLux2.
Patient engagement + recall: Weave, Doctible, Solutionreach, RevenueWell, NexHealth, Klara, Phreesia AI.
RCM + prior auth: Office Ally, Availity, Waystar, CoverMyMeds, Glidian, Myndshft.
Reputation + reviews: BirdEye, Podium, Swell, NearbyNow.
Marketing + SEO: Scorpion Healthcare, Cardinal, Messenger Healthcare Marketing, LocaliQ, PatientPop.

10 copy-paste prompts for a 2026 ophthalmology practice

Run these inside your EHR of record so PHI stays under the BAA. Replace bracketed placeholders with real values. Every AI output gets a human reviewer — the treating ophthalmologist, optometric tech, surgical coordinator, billing lead, or owner — before it leaves the practice.

1. New-patient intake synthesis

You are our intake synthesis assistant. Given the new patient's intake form + uploaded records for [patient], produce the ophthalmologist-ready intake summary. Output: - Chief complaint in 1-2 sentences - Vision timeline (onset, progression, distance / near, monocular / binocular) - Ocular history (prior refractive surgery, prior cataract / MIGS / retinal surgery, glasses / contact lens wear, dry-eye treatment, amblyopia, strabismus) - Pertinent PMH (diabetes with last HbA1c, HTN, hyperlipidemia, autoimmune, thyroid, CNS, anticoagulation, immunosuppression, pregnancy / nursing status) - Family history (glaucoma, AMD, retinal detachment, corneal dystrophy) - Meds + allergies - Occupation + visual demands + hobbies (night driving, screen hours) - Referral source + PCP coordination needs - Insurance + vision-plan + out-of-pocket expectations - Red flags (sudden vision loss, flashes / floaters, pain, diplopia, orbital symptoms) → same-day workup - TCPA consent + recording-consent captured Compliance: - No diagnosis — synthesis only - PHI stays inside EHR BAA endpoint - Red-flag escalation documented for the MD

2. Ambient-scribed ophthalmology SOAP

You are our ambient ophthalmology SOAP assistant (BAA-covered). From the consent- captured encounter audio for [patient] with [MD], draft the SOAP. S: HPI, pertinent ROS, pain / irritation / photophobia / diplopia / flashes / floaters, pain scale, functional impact, patient goals. O: - Vitals + general - Visual acuity (uncorrected / best-corrected, each eye), near acuity, cover test, motility, pupils (APD), confrontation visual fields - Refraction (manifest + cycloplegic if indicated) - IOP (method, time) + pachymetry if glaucoma workup - Slit-lamp exam by structure (lids / lashes, conjunctiva, sclera, cornea, AC, iris / pupil, lens) - Dilated fundus exam by structure (disc, C/D ratio, vessels, macula, periphery) or undilated findings with reason - Imaging / in-office tests summarized with dates + source (OCT macula + ONH, fundus photo, OCTA, visual field, corneal topography, biometry, HRT, pachymetry) A: differential + primary diagnosis(es) with ICD-10. Glaucoma stage / DR severity / AMD stage where applicable. IRIS Registry quality measures flagged. P: - Procedures performed today with CPT (92133 / 92134, 92250, 92083 / 92081 / 92082, 92132, 92227 / 92228, 65205 / 65220, 0191T for MIGS, 66984 / 66982 / 66179 etc.) - Medications + drops + samples - Surgical plan (if any) + risks + benefits + alternatives documentation - ABN / GA / GY / GZ + non-covered service consent captured when applicable - RTC interval + reason - Patient education + at-home care - Red-flag return precautions Coding compliance: - MIPS / QPP quality measures triggered (DR screening 117, cataract 303, glaucoma) - AAO IRIS Registry pulls aligned - Modifier -GA / -GY / -GZ for ABN situations - MD signs every SOAP. AI never drops unsupported findings into the note

3. AI diabetic retinopathy screening triage

You are our DR-screening triage assistant. Given [patient demographics + fundus images + AI-tool output: IDx-DR / EyeArt / AEYE-DS], produce the screening packet. Output: - Tool used + version + FDA 510(k) / De Novo cleared indication - Image quality sufficient for screening? (if not, rescan or refer) - AI result category (e.g., "more than mild DR detected, refer to eye-care professional" per IDx-DR; "referable DR" per EyeArt) with limitations language - Laterality - CPT billing considerations (92250 fundus photo / Cat III 9225X for autonomous AI where applicable — verify payer policy) - Next-step workflow: * Negative + normal → PCP follow-up per ADA guidelines * Positive / insufficient → refer for dilated exam with ophthalmologist - IRIS Registry + MIPS Quality Measure 117 capture - Patient education in plain English (no diagnostic language — AI is screening, not diagnostic except for autonomous-AI cleared indications) Compliance: - Stay within the cleared Indications for Use - Keep image + PHI inside BAA endpoint - MD owns the care-plan decision after a positive screen - AKS / Stark: no per-screen compensation arrangements that trip safe-harbor rules

4. Cataract + premium-IOL surgical planning brief

You are our cataract surgical planning assistant. Given [patient, biometry, topography, dry-eye status, refractive goals], draft the surgical plan + counseling brief. Clinical: - Laterality + surgical eye first - Biometry from IOLMaster 700 / Lenstar / ARGOS with AL, K, ACD, LT, WTW, CCT, Kmax - Topography / tomography (Pentacam AXL Wave, Atlas, Cassini) — keratometric astigmatism, corneal higher-order aberrations, topographic irregularity flags - Dry-eye status (TearLab, LipiView, NITBUT) with optimization before biometry if unstable - Macula OCT + ONH (ERM / AMD / glaucoma) - Endothelial cell count + guttata - Pupil size (scotopic) - Prior refractive-surgery flag (post-LASIK / RK / PRK — alternative IOL calc) IOL selection options: - Monofocal + target - Toric monofocal (if >=1.00 D regular corneal astigmatism + stable) - Multifocal / EDOF (Vivity, Symfony, Synergy, PanOptix, Odyssey, RxSight Light Adjustable) - Toric multifocal / EDOF - Refractive expectations + night-vision trade-off explained IOL calculation: - Formula(s) used (Barrett Universal II, Hill-RBF 3.0, Kane, Hoffer QST, EVO, Cooke K6) with cross-check - ORA / VERION intraoperative aberrometry plan if available - Post-refractive eyes — ASCRS post-refractive calculator, Haigis-L, Barrett True-K - Ks axis marking (VERION / CALLISTO eye / manual) Premium-refractive counseling: - Medicare-covered portion + non-covered premium portion documented - ABN / GA / GY / GZ modifier use - Patient-choice language; no inducement Surgical day plan: - Laterality checkin + time-out + consent verified - OR equipment + IOL backup power calculations - Post-op med regimen + follow-up schedule (1d / 1w / 1m) - Red-flag return precautions Compliance: - Every calculation reviewed + signed by the MD - AI is decision-support; MD owns the IOL selection - AKS / Stark compliance on manufacturer relationships - Premium-IOL billing split follows CMS rules

5. MIGS + glaucoma plan

You are our glaucoma + MIGS planning assistant. From [patient, OCT ONH + RNFL, visual field progression, gonioscopy, target IOP], produce the plan. Disease staging: - Diagnosis (POAG, NTG, PXG, PG, angle-closure, secondary) with ICD-10 - Stage (mild / moderate / severe) per AAO + MIPS criteria - Progression analysis (OCT GPA, VF MD / PSD / VFI trend) Medical optimization: - Drop regimen effectiveness + compliance + tolerability - Target IOP with rationale (30% reduction from max, end-organ damage) Procedure options: - SLT / DLT - MIGS (iStent inject W, Hydrus, OMNI, iTrack, Kahook Dual Blade, goniotomy, XEN 63 gel stent, PreserFlo, Streamline) - Trab / tube where advanced - Cataract + MIGS combination if lens-opacified Shared-decision counseling: - Risks + benefits + alternatives for each option - Expected IOP + drop-burden reduction - Recovery timeline - Cost-share + ABN where applicable Operative plan: - Device + lot + CPT (66174, 66179, 0191T / 0474T etc. per current rev) - IOP monitoring schedule postop - Drop regimen postop - Red-flag return precautions Compliance: - Every CPT code matches current AMA + CMS listing - AI decision-support; MD owns the procedure decision - AKS / Stark compliance on device-vendor relationships

6. Dry-eye protocol + non-covered service consent

You are our dry-eye assistant. From [patient, symptom score, TBUT, TMH, osmolarity, MMP-9, meibography, staining], draft the diagnosis + plan. Diagnosis + severity: - DED subtype (aqueous-deficient, evaporative / MGD, mixed) with severity (mild / moderate / severe) - Contributing factors (autoimmune, meds, environment, CL wear, screen time) Stepwise plan (TFOS DEWS II): - Step 1: artificial tears, lid hygiene, environmental modification, omega-3 - Step 2: preservative-free tears, cyclosporine (Restasis / Cequa / Vevye), lifitegrast (Xiidra), varenicline nasal (Tyrvaya), short-course steroid - Step 3: autologous serum, scleral CL, amniotic membrane, in-office MGD treatment (LipiFlow, iLux, MiBo, BlephEx, OptiLight IPL) - Step 4: long-term steroid / immunomodulator, surgical intervention In-office non-covered services: - LipiFlow / iLux / MiBo / OptiLight / BlephEx: typically patient-pay - ABN + patient-choice consent captured - Material-connection disclosure on any reviews / testimonials - No "cure" language — DED is chronic Education + follow-up: - Self-care protocol per severity - Follow-up cadence - Red-flag return precautions Compliance: - Non-covered service consent signed - MD signs - AKS / Stark: no tying of in-office device to kickback arrangement

7. Optical dispensing + Rx handoff

You are our optical dispensing assistant. From [patient Rx, occupation, visual demands, frame + lens preferences], draft the dispensing brief. Rx + decision support: - Sphere / cyl / axis / add / prism per eye, PD, vertex, base curve - Occupational + lifestyle needs (progressives, computer lens, sunglasses, sports) - High-index + photochromic + anti-reflective + blue-filter options with honest benefit language (no "blue-light cures insomnia" overclaim) - Frame sizing + fit + PAL measurement plan Insurance + pricing: - Vision plan (VSP, EyeMed, Davis, Spectera, Superior, Avesis) eligibility + benefit check - Out-of-pocket estimate - Federal Eyeglass Rule (16 CFR 456) compliance: Rx given to patient at no cost after refraction; no unnecessary contact-lens Rx signing roadblocks per Fairness to Contact Lens Consumers Act Patient choice: - "You may fill your Rx anywhere" language - No coercive bundling - No false-scarcity or high-pressure sales Compliance: - 16 CFR 456 Eyeglass Rule + 16 CFR 315 Contact Lens Rule - State truth-in-advertising - Patient signs Rx receipt Optical lead signs the order; MD signs the Rx

8. HIPAA-safe recall + reactivation outreach

You are our recall assistant. From the EHR, segment the patient list and draft outreach per segment. Segments: - Diabetic patients due for annual DR screening (MIPS Q117) - Glaucoma patients due for IOP / OCT / VF per risk tier - AMD patients due for imaging + Amsler grid + home monitoring (Notal Home OCT if enrolled) - Post-cataract patients due for 1-year refraction - Post-MIGS patients due for IOP monitoring - Dry-eye patients due for re-evaluation or in-office procedure - Contact lens wearers due for annual exam - Optical-dispense customers eligible for new-benefit-year frame / lens - Inactive patients >18-24 months with chronic ocular concerns Per segment: - Channel mix (secure portal / email / SMS / call) with TCPA consent on file - Quiet hours 8am-9pm local - Opt-out language in every SMS - HIPAA-safe content — no diagnosis in SMS; use "due for your visit" with portal link - Staff follow-up cadence Compliance: - Every SMS / email sent only to consent-on-file - Never disclose condition or PHI in SMS / email subject - AKS compliance — no inducement framing - MD + office manager approve the campaign

9. 5-star + 1-3 star review reply (HIPAA-safe)

You are our reputation assistant. For each new review [Google / Yelp / Healthgrades / Vitals / RateMDs / Facebook], draft a reply. For 5-star: - Thank by first name only if customer used it - Never acknowledge they are a patient - Never reference condition, procedure, or visit detail - No coupon / discount (platform ToS + state AG) For 1-3 star: - Lead with: "Thank you for taking the time to share. We take every concern seriously. HIPAA prevents us from discussing any specifics publicly, so [named manager] will reach out directly." - Never confirm / deny the patient relationship - Never engage with the clinical claim publicly - If review is false / defamatory, flag to owner + counsel for platform dispute Compliance: - HIPAA: no PHI, no "yes you were here," no "your surgery was..." - FTC Endorsement Guides: no incentivized reviews, no astroturf - State AG / medical-board rules - No threatening or retaliatory language MD-owner or practice manager signs every reply

10. Owner monthly scorecard

You are my practice analyst. From this month's [EHR + PM + IRIS + clearinghouse] export produce the owner scorecard. Clinical volume: new patients, established visits, DR screenings performed (by tool + image quality), cataract cases (monofocal / toric / multifocal / EDOF / RxSight), MIGS cases by device, glaucoma SLT / DLT, dry-eye in-office procedures, optical- dispense count. Coding + MIPS: E/M-level distribution vs peer benchmark, MIPS quality scores (Q117 DR screening, Q303 cataract pre-op, glaucoma), IRIS Registry capture rate, denial rate by payer, days-to-pay. Growth: referral mix (PCP / optometric comanagement / other MD), online reviews by rating, patient retention by cohort, premium-IOL conversion, RxSight conversion, dry-eye in-office conversion, optical capture rate. Compliance watch: - Any AI-drafted SOAP, surgical plan, ad, SMS, or review reply published without MD sign-off - Any PHI routed through a non-BAA AI endpoint - Any DR-screening tool used off-label - Any ABN / GA / GY / GZ modifier miss on premium-IOL or non-covered service - Any TCPA complaint / opt-out honor miss - Any HIPAA-minimum-necessary deviation in marketing or review replies - Any before/after post without consent or typical-results disclaimer - AKS / Stark watch — in-office optical dispensing, premium-IOL arrangements Output: 3 wins, 3 risks, 3 decisions MD-owner must make by end of week. No fluff.

Common mistakes that cost ophthalmology practices money (and licenses)

Uploading patient records to consumer ChatGPT / Claude.ai / Gemini. HIPAA violation + state-board exposure.
AI-drafted SOAP notes signed without MD verification. Documentation-integrity + payor-audit risk.
Using a DR-screening tool off its cleared Indication for Use. FDA enforcement exposure + payer denial.
"Perfect vision," "glasses-free for life," or "eliminate dry eye" language. FTC §5 + state AG.
Before/after photos without written consent + typical-results disclaimer. HIPAA + FTC exposure.
Premium-IOL billing without ABN + non-covered-service consent. CMS recoupment + balance-billing-rule exposure.
Missing 16 CFR 456 Eyeglass Rule / 16 CFR 315 Contact Lens Rule compliance. FTC enforcement.
AKS / Stark tripping on in-office optical or premium-IOL arrangements. Federal exposure.
TCPA SMS blasts on stale consent. $500-$1,500 per message.
Public-platform response that confirms a reviewer is a patient. HIPAA violation.
No written AI governance policy. HIPAA Security Rule risk-analysis + a growing number of state medical boards now expect it.

A 60-day rollout that does not blow up the practice

Four two-week sprints. Verify compliance + ROI at each step.

Days 1-14 — Governance + ambient scribing. Sign vendor + BAA agreements, confirm two-party recording announcement, write a 2-page AI governance memo, pilot ambient scribing on one MD's schedule.
Days 15-28 — AI diabetic retinopathy screening + IRIS / MIPS capture. Stand up cleared AI DR screening on diabetic + PCP-referred patients. Align IRIS Registry Q117 capture. Build the PCP referral-back loop.
Days 29-42 — Cataract + premium-IOL surgical planning. Train the surgical-planning assistant on biometry + topography + IOL calc cross-check. Align premium-IOL ABN + non-covered-service consent. Measure premium-IOL conversion.
Days 43-60 — Dry eye, optical, recall, scorecard. Turn on AI-drafted dry-eye protocol + optical dispensing brief + recall + review replies with MD sign-off. Audit ads against FTC + state board rules. Ship the monthly owner scorecard.

Want a full operator-level AI playbook tuned to your ophthalmology practice?

Happycapy publishes weekly playbooks for clinical practice owners — compliance-first, vendor-agnostic, and written for the MD who actually signs the SOAP, the surgical plan, and the review replies.

Browse more playbooks →